IVIG Compared With IVIG Plus Infliximab in Multisystem Inflammatory Syndrome in Children

CONCLUSIONSPatients with MIS-C initially treated with IVIG plus infliximab compared with those treated with IVIG alone were less likely to require additional therapy and had decreased ICU length of stay, decreased development of left ventricular dysfunction, and more rapid decline in C-reactive protein levels.
Source: PEDIATRICS - Category: Pediatrics Source Type: research